Skip to main content

Table 2 Clinic characteristics of case group (N = 134)

From: The association between family impact and health-related quality of life of children with idiopathic central precocious puberty in Chongqing, China

Variables

N (%)

New diagnosis/follow-up

 New diagnosis

11 (8.2)

 Follow-up

123 (91.8)

Age of diagnosis (years)

 5–7

45 (33.6)

 8–12

89 (66.4)

Disease duration (years)

 < 1

87 (64.9)

 1–2

34 (25.4)

 > 2

13 (9.7)

Type of medical treatment

 GnRHa

107 (79.9)

 GnRHa + GH

27 (20.1)

Route of administration

 Intramuscular injection

90 (67.2)

 Subcutaneous injection

44 (32.8)

Duration of medical treatment (years)

 < 1

98 (73.1)

 1–2

29 (21.6)

 > 2

7 (5.2)

  1. GnRHa gonadotropin release hormone agonist, GH growth hormone